A histologic scoring system for prognosis of patients with alcoholic hepatitis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Gastroenterology

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.gastro.2014.01.018PMID 24440674PMCID PMC3992184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evolution of Translational Omics: Lessons Learned and the Path Forward

  2013cited by this paper
• Liver progenitor cell markers correlate with liver damage and predict short‐term mortality in patients with alcoholic hepatitis

  2012cited by this paper
• EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease

  2012cited by this paper
• EASL clinical practical guidelines: management of alcoholic liver disease.

  2012cited by this paper
• Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis.

  2012cited by this paper
• Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis

  2011cited by this paper
• The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis.

  2011cited by this paper
• Alcoholic liver disease: The buzz may be gone, but the hangover remains

  2010cited by this paper
• Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study

  2010cited by this paper
• The clinical use of HVPG measurements in chronic liver disease

  2009cited by this paper
• Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.

  2009cited by this paper
• Alcoholic hepatitis.

  2009cited by this paper
• A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis

  2008cited by this paper
• Simplified criteria for the diagnosis of autoimmune hepatitis

  2008cited by this paper
• The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids

  2007cited by this paper
• Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

  2007cited by this paper
• Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

  2007cited by this paper
• Prognostic value of hepatic venous pressure gradient for in‐hospital mortality of patients with severe acute alcoholic hepatitis

  2007cited by this paper
• Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score

  2005cited by this paper
• MELD accurately predicts mortality in patients with alcoholic hepatitis

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Management of adult patients with ascites due to cirrhosis

  2004cited by this paper
• LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process.

  2004cited by this paper
• The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club

  2003cited by this paper
• Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

  2002cited by this paper
• Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis.

  2002cited by this paper
• An algorithm for the grading of activity in chronic hepatitis C

  1996cited by this paper
• Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone.

  1996cited by this paper
• Histopathology of cholestasis.

  1995cited by this paper
• Serum bile acids and cholestasis in alcoholic hepatitis. Relationship with usual liver tests and histological features.

  1994cited by this paper
• Significance of megamitochondria in alcoholic liver disease.

  1986cited by this paper
• Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and "cholangitis lenta".

  1982cited by this paper
• The significance of giant mitochondria in liver biopsies as observed by light microscopy.

  1982cited by this paper
• Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

  1981cited by this paper
• Corticosteroid therapy of alcoholic hepatitis.

  1978cited by this paper
• Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

  1978cited by this paper

• Zinc-dependent RNA-binding protein controls hepatocyte senescence and recovery from alcohol-related liver failure

  2026cites this paper
• MG53 mediates skeletal muscle-liver cross-talk and enhances alcohol metabolism in alcoholic liver disease.

  2026cites this paper
• Lipidomics-based plasma signature of alcohol-related hepatitis linked to short-term mortality

  2025cites this paper
• New Approaches to Alcohol-Associated Hepatitis.

  2025cites this paper
• Steatotic Liver Disease: Navigating Pathologic Features, Diagnostic Challenges, and Emerging Insights.

  2025cites this paper
• Cholestasis in Alcohol-Associated Liver Disease

  2025cites this paper
• Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia

  2025cites this paper
• Liver biopsy and acute hepatology in intensive care unit patients

  2025cites this paper
• Therapeutic Options for Alcohol-Associated Hepatitis in Resource-Limited Settings

  2025cites this paper
• Regulatory effect of Chinese Baijiu on gut microbiota and host metabolism.

  2025cites this paper
• Living donor liver transplant for alcohol-associated hepatitis: considerations and global perspectives

  2025cites this paper
• Alcohol-related liver disease

  2025cites this paper
• Neutrophil Recruitment via Hepatocyte IL-1α Drives NETs-Mediated AIM2 Hepatocyte Apoptosis in Alcohol-associated steatohepatitis

  2025cites this paper
• Latest Insights in Alcohol-Related Liver Disease and Alcoholic Hepatitis

  2025cites this paper
• Acute Alcoholic Hepatitis: New and Experimental Medications.

  2025cites this paper
• Longitudinal paired liver biopsies and transcriptome profiling in alcohol-associated hepatitis reveal dynamic changes in cellular senescence

  2025cites this paper
• Management of asymptomatic patients with abnormal liver function tests.

  2025cites this paper
• Co-existing regeneration mechanisms in severe alcohol-related steatohepatitis

  2025cites this paper
• Alcohol Use Disorder and Alcohol-Associated Liver Disease: New Definitions, Screening, and Treatment.

  2024cites this paper
• Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future

  2024cites this paper
• Severe Alcoholic Hepatitis-optimizing Medical Management: Whether we need a Liver Transplant

  2024cites this paper
• Faecal proteomics links neutrophil degranulation with mortality in patients with alcohol-associated hepatitis

  2024cites this paper
• Impact of mitochondrial lipid alterations on liver disease mechanisms and progression

  2024cites this paper
• Research Priorities and Future Landscape of Clinical Trials in Alcohol-Associated Liver Disease.

  2024cites this paper
• Short-term exposure of dairy cows to pyrrolizidine alkaloids from tansy ragwort (Jacobaea vulgaris Gaertn.): effects on organs and indicators of energy metabolism

  2024cites this paper
• Immunology and treatments of fatty liver disease

  2024cites this paper
• Clinical criteria accurately diagnose severe but not moderate alcohol-associated hepatitis: A systematic review and meta-analysis

  2024cites this paper
• Cholestatic insult triggers alcohol-associated hepatitis in mice

  2024cites this paper
• AASLD Practice Guideline on imaging-based non-invasive liver disease assessments of hepatic fibrosis and steatosis.

  2024cites this paper
• Severe acute liver disease in adults: Contemporary role of histopathology

  2024cites this paper
• Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis

  2024cites this paper
• Alcohol-associated liver disease: Natural history, management and novel targeted therapies

  2024cites this paper
• IL-1 Signal Inhibition in Alcohol-Related Hepatitis: a randomised, double-blind, placebo-controlled trial of canakinumab.

  2024cites this paper
• Drug induced cholestatic liver diseases.

  2024cites this paper
• Platelets in Alcohol-Associated Liver Disease: Interaction With Neutrophils

  2024cites this paper
• MICOS Complex Loss Governs Age-Associated Murine Mitochondrial Architecture and Metabolism in the Liver, While Sam50 Dictates Diet Changes

  2024cites this paper
• Impact of keratins 8 and 18 genetic variants on the severity of alcoholic liver disease.

  2024cites this paper
• Alcohol-Associated Hepatitis: Short- and Long-Term Management

  2024cites this paper
• Model of disease severity in alcoholic hepatitis and novel prognostic insights

  2024cites this paper
• Histological characteristics in patients admitted to the hospital with alcoholic hepatitis complicated by acute-on-chronic liver failure

  2024cites this paper
• AASLD Practice Guideline on blood-based non-invasive liver disease assessments of hepatic fibrosis and steatosis.

  2024cites this paper
• Neutrophils insert elastase into hepatocytes to regulate calcium signaling in alcohol-associated hepatitis

  2024cites this paper
• SIRS criteria versus qSOFA score in patients with severe alcohol-related hepatitis

  2024cites this paper
• Solving the puzzle of fibrosis resolution in alcohol-associated liver disease: An insight from KDM5 demethylases and LXR activation.

  2024cites this paper
• Non-Invasive Biomarkers for Differentiating Alcohol Associated Hepatitis from Acute Decompensation in Patients with ALD

  2024cites this paper
• A comprehensive review of diagnosis and management of alcohol-associated hepatitis

  2024cites this paper
• In vivo Bruton’s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis

  2024cites this paper
• Interleukin-1 inhibition in alcohol-associated hepatitis: are we hitting the right target?

  2024cites this paper
• Exome-wide association analysis identifies novel risk loci for alcohol-associated hepatitis

  2024cites this paper
• Infections in Patients with Severe Alcoholic Hepatitis: A Retrospective Study

  2023cites this paper
• Ductular reaction-associated neutrophils promote biliary epithelium proliferation in chronic liver disease.

  2023cites this paper
• Management of Patients After Treatment of Severe Alcohol-associated Hepatitis

  2023cites this paper
• Cell transplantation-based regenerative medicine in liver diseases

  2023cites this paper
• Acute alcohol‐associated hepatitis: Latest findings in non‐invasive biomarkers and treatment

  2023cites this paper
• Megamitochondria plasticity: function transition from adaption to disease.

  2023cites this paper
• How to manage alcohol-related liver disease: A case-based review

  2023cites this paper
• Therapeutic targets in alcohol-associated liver disease: progress and challenges

  2023cites this paper
• The role of neutrophils in alcohol-related hepatitis.

  2023cites this paper
• Alcohol-related hepatitis: A review article

  2023cites this paper
• Current and future treatment for alcoholic‐related liver diseases

  2023cites this paper
• Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis

  2023cites this paper
• Extracellular volume fraction obtained by dual-energy CT depicting the etiological differences of liver fibrosis

  2023cites this paper
• Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease

  2023cites this paper
• IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice

  2023cites this paper
• Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell Reprogramming

  2023cites this paper
• Hépatite alcoolique sévère

  2023cites this paper
• Extra‐hepatic morbidity and mortality in alcohol‐related liver disease: Systematic review and meta‐analysis

  2023cites this paper
• Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming.

  2023cites this paper
• Acute Kidney Injury in Alcohol-Associated Hepatitis: More than a Bystander.

  2023cites this paper
• Enhanced diagnosis and prognosis of severe alcoholic hepatitis using novel metabolomic biomarkers.

  2023cites this paper
• Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis

  2023cites this paper
• Liver surface nodularity and ascites are associated with mortality risk in acute alcohol-associated hepatitis.

  2023cites this paper
• [Alcoholic liver disease - 2023].

  2023cites this paper
• Imaging of Alcohol-Associated Liver Disease.

  2023cites this paper
• Digital pathology for nonalcoholic steatohepatitis assessment

  2023cites this paper
• Experimental Models for Studying Structural and Functional State of the Pathological Liver (Review)

  2023cites this paper
• Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review

  2023cites this paper
• Kaempferol ameliorated alcoholic liver disease through inhibiting hepatic bile acid synthesis by targeting intestinal FXR-FGF15 signaling.

  2023cites this paper
• Alcohol-associated liver disease: epidemiology and management.

  2023cites this paper
• Prognostic models in alcohol-related liver disease and alcohol-related hepatitis.

  2023cites this paper
• Management of alcoholic hepatitis: A clinical perspective

  2023cites this paper
• CAQ Corner: The practical assessment and management of sarcopenia, frailty, and malnutrition in patients with cirrhosis

  2022cites this paper
• Hepatic protein and phosphoprotein signatures of alcohol-associated cirrhosis and hepatitis.

  2022cites this paper
• Management of Alcohol-Related Liver Disease and Its Complications

  2022cites this paper
• Article title: Subclinical versus advanced forms of alcohol-related liver disease: need for early detection

  2022cites this paper
• Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection

  2022influential citation
• MiR-223 as a Regulator and Therapeutic Target in Liver Diseases

  2022cites this paper
• Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis

  2022cites this paper
• Liver biopsy for assessment of chronic liver diseases: a synopsis

  2022cites this paper
• Serum keratin 19 (CYFRA21‐1) is a prognostic biomarker in severe alcoholic hepatitis

  2022cites this paper
• Response to Philips et al.

  2022cites this paper
• Current Medical Treatment for Alcohol-Associated Liver Disease.

  2022cites this paper
• Alcohol‐related liver disease

  2022cites this paper
• The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial

  2022cites this paper
• Infections in Alcoholic Hepatitis

  2022cites this paper
• Impaired regulation of PMCA activity by defective CFTR expression promotes epithelial cell damage in alcoholic pancreatitis and hepatitis

  2022cites this paper
• Alcohol-Associated Hepatitis.

  2022cites this paper
• Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

  2022cites this paper
• Effect of an Integrated Transplantation Mental Health Program on Alcohol Relapse After Liver Transplantation for Severe Alcoholic Hepatitis: A Single-Center Prospective Study.

  2022cites this paper
• Artificial Intelligence for Detecting and Quantifying Fatty Liver in Ultrasound Images: A Systematic Review

  2022cites this paper